Understanding the Mechanisms of Resistance in

Animals Biomarkers, Tumor Carcinoma, Non-Small-Cell Lung / drug therapy Circulating Tumor DNA Clinical Decision-Making Disease Management Drug Resistance, Neoplasm / genetics ErbB Receptors / genetics Humans Liquid Biopsy Lung Neoplasms / drug therapy Molecular Targeted Therapy Mutation Protein Kinase Inhibitors / pharmacology
circulating cell-free DNA epidermal growth factor receptor liquid biopsy mechanisms of resistance non-Small Cell Lung Cancer tyrosine kinase inhibitors

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Aug 2019
Historique:
received: 29 06 2019
revised: 07 08 2019
accepted: 09 08 2019
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 17 1 2020
Statut: epublish

Résumé

Liquid biopsy has emerged as an alternative source of nucleic acids for the management of Epidermal Growth Factor Receptor (

Identifiants

DOI: 10.3390/ijms20163951 PMID: 31416192 PMC: PMC6720634
pubmed: 31416192
pii: ijms20163951
doi: 10.3390/ijms20163951
pmc: PMC6720634
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Circulating Tumor DNA 0
Protein Kinase Inhibitors 0
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Oncogene. 2000 Nov 20;19(49):5582-9
pubmed: 11114738
Science. 2002 Jul 5;297(5578):63-4
pubmed: 12098689
Trends Cell Biol. 2003 Jun;13(6):328-35
pubmed: 12791299
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12718-23
pubmed: 14555767
PLoS Med. 2005 Jan;2(1):e17
pubmed: 15696205
N Engl J Med. 2005 Feb 24;352(8):786-92
pubmed: 15728811
Science. 2007 May 18;316(5827):1039-43
pubmed: 17463250
Cancer Metastasis Rev. 2008 Mar;27(1):85-94
pubmed: 18175071
J Thorac Oncol. 2008 Apr;3(4):331-9
pubmed: 18379349
Nat Rev Drug Discov. 2008 Jun;7(6):504-16
pubmed: 18511928
J Clin Oncol. 2009 Apr 1;27(10):1667-74
pubmed: 19255323
N Engl J Med. 2009 Sep 3;361(10):947-57
pubmed: 19692680
Trends Cell Biol. 2009 Oct;19(10):542-51
pubmed: 19758803
Cancer Cell. 2010 Jan 19;17(1):77-88
pubmed: 20129249
Am J Pathol. 2010 Nov;177(5):2191-204
pubmed: 20934974
Sci Transl Med. 2011 Mar 23;3(75):75ra26
pubmed: 21430269
J Clin Oncol. 2011 May 20;29(15):2046-51
pubmed: 21483012
Clin Cancer Res. 2011 Sep 1;17(17):5530-7
pubmed: 21775534
Lancet Oncol. 2012 Mar;13(3):239-46
pubmed: 22285168
J Thorac Oncol. 2012 Jun;7(6):1061-3
pubmed: 22588159
Curr Med Chem. 2012;19(22):3689-700
pubmed: 22680928
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2127-33
pubmed: 22773810
J Clin Oncol. 2012 Sep 10;30(26):3287-96
pubmed: 22869872
Mol Oncol. 2013 Feb;7(1):112-20
pubmed: 23102728
Clin Chem. 2013 Jan;59(1):158-67
pubmed: 23284016
Clin Cancer Res. 2013 Apr 15;19(8):2240-7
pubmed: 23470965
J Clin Oncol. 2013 Nov 10;31(32):4105-14
pubmed: 24101053
Head Neck. 2014 Nov;36(11):1547-54
pubmed: 24123531
Nat Med. 2013 Nov;19(11):1389-400
pubmed: 24202392
J Clin Oncol. 2014 Feb 20;32(6):579-86
pubmed: 24449238
J Natl Compr Canc Netw. 2014 Jan;12(1):6-11; quiz 11
pubmed: 24453288
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Ther Adv Med Oncol. 2014 Mar;6(2):43-51
pubmed: 24587830
Expert Rev Mol Diagn. 2014 May;14(4):453-68
pubmed: 24725257
BMC Med Genomics. 2014 May 13;7:23
pubmed: 24885028
Front Oncol. 2014 May 27;4:127
pubmed: 24904836
Cancers (Basel). 2014 Aug 19;6(3):1736-52
pubmed: 25256830
Nat Med. 2014 Dec;20(12):1472-8
pubmed: 25326804
Clin Chem. 2015 Jan;61(1):112-23
pubmed: 25388429
Lancet Oncol. 2015 Feb;16(2):141-51
pubmed: 25589191
Lancet Oncol. 2015 Apr;16(4):e165-72
pubmed: 25846096
Cancer Res. 2015 Jun 15;75(12):2489-500
pubmed: 25870145
Cancer Discov. 2015 Jul;5(7):713-22
pubmed: 25934077
Nat Med. 2015 Jun;21(6):560-2
pubmed: 25939061
Clin Cancer Res. 2015 Sep 1;21(17):3924-33
pubmed: 25964297
Ann Oncol. 2015 Oct;26(10):2066-72
pubmed: 26153496
Ann Oncol. 2015 Oct;26(10):2073-8
pubmed: 26269204
Cancer Res. 2015 Oct 15;75(20):4372-83
pubmed: 26282169
J Thorac Oncol. 2015 Oct;10(10):1437-43
pubmed: 26295376
J Cancer Res Ther. 2015 Aug;11 Suppl 1:C80-3
pubmed: 26323931
Sci Rep. 2015 Sep 24;5:14447
pubmed: 26400668
Clin Cancer Res. 2016 Mar 1;22(5):1103-10
pubmed: 26446944
Clin Cancer Res. 2016 Feb 15;22(4):915-22
pubmed: 26459174
J Thorac Oncol. 2015 Dec;10(12):1736-44
pubmed: 26473643
Lung Cancer. 2015 Dec;90(3):509-15
pubmed: 26494259
Oncotarget. 2016 Feb 9;7(6):6984-93
pubmed: 26755650
J Thorac Oncol. 2016 Jan;11(1):e1-4
pubmed: 26762749
Oncotarget. 2017 Feb 21;8(8):13611-13619
pubmed: 26799287
JAMA Oncol. 2016 Aug 1;2(8):1014-22
pubmed: 27055085
J Thorac Dis. 2016 Mar;8(3):E217-20
pubmed: 27076973
J Clin Oncol. 2016 Oct 1;34(28):3375-82
pubmed: 27354477
J Thorac Oncol. 2016 Oct;11(10):1736-44
pubmed: 27448761
Sci Rep. 2016 Aug 24;6:31985
pubmed: 27555497
Clin Cancer Res. 2016 Dec 1;22(23):5772-5782
pubmed: 27601595
Transl Lung Cancer Res. 2016 Aug;5(4):420-3
pubmed: 27655109
Ann Oncol. 2016 Sep;27(suppl 5):v1-v27
pubmed: 27664245
Sci Rep. 2016 Oct 13;6:35249
pubmed: 27734950
Oncol Lett. 2016 Nov;12(5):4009-4012
pubmed: 27895763
Biomol Detect Quantif. 2014 Aug 20;1(1):8-22
pubmed: 27920993
J Thorac Oncol. 2017 Mar;12(3):567-572
pubmed: 27923714
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Oncotarget. 2017 Feb 14;8(7):12501-12516
pubmed: 27980215
Pharmacol Res. 2017 Mar;117:406-415
pubmed: 28089942
Nat Commun. 2017 Mar 13;8:14768
pubmed: 28287083
Clin Lung Cancer. 2017 Sep;18(5):583-588
pubmed: 28341106
J Thorac Oncol. 2017 Jul;12(7):1061-1070
pubmed: 28428148
Nature. 2017 Apr 26;545(7655):446-451
pubmed: 28445469
Blood. 2017 Aug 10;130(6):742-752
pubmed: 28483762
J Thorac Oncol. 2017 Nov;12(11):1723-1727
pubmed: 28662863
Sci Rep. 2017 Jul 26;7(1):6595
pubmed: 28747773
J Thorac Oncol. 2017 Nov;12(11):1728-1732
pubmed: 28843359
Ann Oncol. 2017 Sep 1;28(9):2248-2255
pubmed: 28911086
Oncotarget. 2017 May 4;8(35):59986-59990
pubmed: 28938699
Clin Cancer Res. 2017 Dec 1;23(23):7351-7359
pubmed: 28947568
Lancet Oncol. 2017 Nov;18(11):1454-1466
pubmed: 28958502
Arch Pathol Lab Med. 2018 Feb;142(2):163-167
pubmed: 29106293
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Oncotarget. 2017 Sep 22;8(52):90557-90578
pubmed: 29163853
Contemp Oncol (Pozn). 2017;21(3):254-258
pubmed: 29180936
Lung Cancer. 2018 Jan;115:21-27
pubmed: 29290257
Sci Rep. 2018 Jan 31;8(1):1955
pubmed: 29386539
J Thorac Oncol. 2018 Jun;13(6):821-830
pubmed: 29505901
Br J Cancer. 2018 Mar 20;118(6):820-824
pubmed: 29509748
PLoS One. 2018 Mar 16;13(3):e0194630
pubmed: 29547634
Lung Cancer. 2018 Apr;118:105-110
pubmed: 29571987
Thorac Cancer. 2018 May;9(5):640-645
pubmed: 29582563
Dtsch Arztebl Int. 2018 Mar 9;115(10):169-174
pubmed: 29587961
JAMA Oncol. 2018 May 1;4(5):739-742
pubmed: 29596544
J Thorac Oncol. 2018 Jun;13(6):e89-e91
pubmed: 29596911
Ann Oncol. 2018 Jun 1;29(6):1445-1453
pubmed: 29635542
Cancer Biomark. 2018;22(2):267-274
pubmed: 29660899
Respir Med Case Rep. 2018 Mar 01;23:188-190
pubmed: 29719814
Pharmacogenomics. 2018 Jun 1;19(8):727-740
pubmed: 29785875
EMBO Mol Med. 2018 Jun;10(6):
pubmed: 29848757
Biochimie. 2018 Aug;151:27-36
pubmed: 29857182
Oncotarget. 2018 May 25;9(40):26195-26208
pubmed: 29899852
Case Rep Oncol. 2018 May 29;11(2):323-329
pubmed: 29928211
Oncol Lett. 2018 Jun;15(6):9811-9817
pubmed: 29928355
Respir Med Case Rep. 2018 Mar 16;24:19-21
pubmed: 29977749
Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1761-1766
pubmed: 30049184
JAMA Oncol. 2018 Nov 1;4(11):1527-1534
pubmed: 30073261
J Thorac Oncol. 2018 Nov;13(11):1705-1716
pubmed: 30121392
ACS Med Chem Lett. 2018 Jul 23;9(8):779-782
pubmed: 30128066
J Clin Oncol. 2018 Nov 1;36(31):3101-3109
pubmed: 30156984
J Thorac Oncol. 2018 Sep;13(9):e169-e172
pubmed: 30166014
Sci Rep. 2018 Sep 6;8(1):13379
pubmed: 30190486
J Exp Clin Cancer Res. 2018 Sep 14;37(1):226
pubmed: 30217217
Clin Cancer Res. 2018 Dec 15;24(24):6195-6203
pubmed: 30228210
Cancer Discov. 2018 Dec;8(12):1529-1539
pubmed: 30257958
Respir Med Case Rep. 2018 Oct 06;25:261-263
pubmed: 30310765
Mol Cancer Ther. 2019 Jan;18(1):112-126
pubmed: 30322949
JAMA Oncol. 2019 Feb 1;5(2):173-180
pubmed: 30325992
J Thorac Oncol. 2018 Nov;13(11):e232-e234
pubmed: 30368417
J Thorac Oncol. 2019 Feb;14(2):193-202
pubmed: 30391576
Br J Cancer. 2018 Nov;119(10):1252-1258
pubmed: 30397287
Cancer Sci. 2019 Jan;110(1):433-442
pubmed: 30407700
Expert Rev Anticancer Ther. 2019 Jan;19(1):19-28
pubmed: 30462523
Target Oncol. 2019 Feb;14(1):75-83
pubmed: 30539501
Case Rep Oncol. 2019 Jan 21;12(1):91-97
pubmed: 30792648
Lung Cancer. 2019 Mar;129:72-74
pubmed: 30797494
Cancers (Basel). 2019 Mar 10;11(3):null
pubmed: 30857358
Lung Cancer (Auckl). 2019 Mar 12;10:21-26
pubmed: 30881166
J Thorac Oncol. 2019 Apr;14(4):e70-e72
pubmed: 30922580
BMC Cancer. 2019 Apr 30;19(1):410
pubmed: 31039766
Cancer Sci. 2019 Jul 30;:null
pubmed: 31361375

Auteurs

Marzia Del Re (M)

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. marzia.delre@gmail.com.
ORCID: 0000-0001-7343-6161

Stefania Crucitta (S)

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Giulia Gianfilippo (G)

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Antonio Passaro (A)

Division of Thoracic Oncology, European Institute of Oncology, 20141 Milano, Italy.
ORCID: 0000-0002-7575-3870

Iacopo Petrini (I)

General Pathology, Department of Translational Research & New Technologies in Surgery and Medicine, University of Pisa, 56126 Pisa, Italy.

Giuliana Restante (G)

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
ORCID: 0000-0002-6748-5562

Angela Michelucci (A)

Unit of Molecular Genetics, Department of Laboratory Medicine, University Hospital, 56126 Pisa, Italy.

Stefano Fogli (S)

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Filippo de Marinis (F)

Division of Thoracic Oncology, European Institute of Oncology, 20141 Milano, Italy.

Camillo Porta (C)

Department of Internal Medicine, University of Pavia, 27100 Pavia, Italy.
Division of Translational Oncology, I.R.C.C.S. Istituti Clinici Scientifici Maugeri, 27100 Pavia, Italy.

Antonio Chella (A)

Unit of Respiratory Medicine, Department of Critical Area and Surgical, Medical and Molecular Pathology, University Hospital, 56126 Pisa, Italy.
ORCID: 0000-0002-4325-759X

Romano Danesi (R)

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
ORCID: 0000-0002-4414-8934

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumeurs des bronches › Carcinome bronchogénique › Carcinome pulmonaire non à petites cellules › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ADN › ADN tumoral › ADN tumoral circulant › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Diagnostic › Prise de décision clinique › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Prise en charge de la maladie › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance aux médicaments antinéoplasiques › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur facteur croissance › Récepteurs ErbB › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Techniques d'investigation › Techniques cytologiques › Cytodiagnostic › Biopsie › Biopsie liquide › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Thérapie moléculaire ciblée › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Understanding the Mechanisms of Resistance in
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de protéines kinases › Understanding the Mechanisms of Resistance in